Cargando…
Modeling Smith-Lemli-Opitz syndrome with iPS cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes
Smith-Lemli-Opitz syndrome (SLOS) is a malformation disorder caused by mutations in DHCR7, impairing the reduction of 7-dehydrocholesterol to cholesterol. SLOS results in cognitive impairment, behavioral abnormalities, and nervous system defects, though neither cellular targets nor affected signalin...
Autores principales: | Francis, Kevin R., Ton, Amy N., Xin, Yao, O’Halloran, Peter E., Wassif, Christopher A., Malik, Nasir, Williams, Ian M., Cluzeau, Celine V., Trivedi, Niraj S., Pavan, William J., Cho, Wonhwa, Westphal, Heiner, Porter, Forbes D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4823163/ https://www.ncbi.nlm.nih.gov/pubmed/26998835 http://dx.doi.org/10.1038/nm.4067 |
Ejemplares similares
-
Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update
por: Thurm, Audrey, et al.
Publicado: (2016) -
Smith-Lemli-Opitz-syndrome
por: Gedam, Rachana, et al.
Publicado: (2012) -
A Placebo-Controlled Trial of Simvastatin Therapy in Smith-Lemli-Opitz Syndrome
por: Wassif, Christopher A., et al.
Publicado: (2016) -
Cholesterol deficiency in a mouse model of Smith-Lemli-Opitz syndrome reveals increased mast cell responsiveness
por: Kovarova, Martina, et al.
Publicado: (2006) -
Smith-Lemli-Opitz Syndrome: Bosnian and Herzegovinian Experience
por: Begic, N, et al.
Publicado: (2021)